<?xml version="1.0" encoding="UTF-8"?>
<clinical_study rank="48776">
  <!-- This xml conforms to an XML Schema at:
    http://clinicaltrials.gov/ct2/html/images/info/public.xsd
 and an XML DTD at:
    http://clinicaltrials.gov/ct2/html/images/info/public.dtd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on June 04, 2014</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>http://clinicaltrials.gov/show/NCT02145728</url>
  </required_header>
  <id_info>
    <org_study_id>MGH-14-UL</org_study_id>
    <nct_id>NCT02145728</nct_id>
  </id_info>
  <brief_title>The Effect of Cognitive Functional Therapy on Patients With Non-specific Chronic Low Back Pain</brief_title>
  <official_title>The Effect of Cognitive Functional Therapy on Patients With Non-specific Chronic Low Back Pain: a Multi-centre Randomized Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University of Limerick</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Curtin University of Technology</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Katholieke Universiteit Leuven</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Mayo General Hospital, Ireland</agency>
      <agency_class>Other</agency_class>
    </collaborator>
    <collaborator>
      <agency>Health Service Executive, Ireland</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>University of Limerick</source>
  <oversight_info>
    <authority>Ireland: Research Ethics Committee</authority>
    <authority>Ireland: Health Service Executive</authority>
    <has_dmc>Yes</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to evaluate whether individual cognitive functional therapy
      (CFT), when compared to group exercise classes is effective in reducing pain and disability
      in patients with non-specific chronic low back pain.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      A multi-centre randomised study with 6 month, 12 month and 36 month follow up will be used.
      Patient with non- specific chronic low back pain will be assessed for eligibility. The
      patients fitting the inclusion criteria will be randomised to receive either the individual
      CFT or the group classes consisting of education and exercise.  Participants' pain,
      disability, socio-economic status, beliefs, fear, catastrophizing, self-efficacy,  general
      health, stress levels, as well as number and cost of treatments will be evaluated using a
      range of outcome measures at the start and on completion of the treatment. Patients will
      receive another copy of the questionnaires in the post at 6 month, 12 months and 36 months
      after treatment to reassess clinical outcomes. If a participant does not respond to
      follow-up, they will be telephoned to ask if they wish to complete the questionnaires.
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date>May 2014</start_date>
  <completion_date type="Anticipated">December 2017</completion_date>
  <primary_completion_date type="Anticipated">December 2017</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <study_design>Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Single Blind (Outcomes Assessor), Primary Purpose: Treatment</study_design>
  <primary_outcome>
    <measure>Change in Oswestry Disability Index (ODI)</measure>
    <time_frame>Baseline, post intervention (at 8-14 weeks), 6, 12 and 36 months</time_frame>
    <safety_issue>No</safety_issue>
    <description>Used to assess change in disability levels over the course of the trial and follow-up</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Numerical rating scale (NRS)</measure>
    <time_frame>Baseline, post intervention (at 8-14 weeks), 6, 12 and 36 months</time_frame>
    <safety_issue>No</safety_issue>
    <description>Measures pain intensity</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Socio-economic Conditions Index</measure>
    <time_frame>Baseline</time_frame>
    <safety_issue>No</safety_issue>
    <description>Measures socio-economic status</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Back Pain Beliefs Questionnaire</measure>
    <time_frame>Baseline, post intervention (at 8-14 weeks), 6, 12 and 36 months</time_frame>
    <safety_issue>No</safety_issue>
    <description>Assess a person's beliefs about their back pain</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Physical activity subscale of the Fear-Avoidance Beliefs Questionnaire (FABQ)</measure>
    <time_frame>Baseline, post intervention (at 8-14 weeks), 6, 12 and 36 months</time_frame>
    <safety_issue>No</safety_issue>
    <description>Assesses a person's level of fear-avoidance beliefs regarding physical activities.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>The catastrophising subscale of the Coping Strategies Questionnaire (CSQ)</measure>
    <time_frame>Baseline, post intervention (at 8-14 weeks), 6, 12 and 36 months</time_frame>
    <safety_issue>No</safety_issue>
    <description>Assesses level of pain catastrophizing.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Pain Self- Efficacy Questionnaire (PSEQ)</measure>
    <time_frame>Baseline, post intervention (at 8-14 weeks), 6, 12 and 36 months</time_frame>
    <safety_issue>No</safety_issue>
    <description>Assesses level of pain self-efficacy</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Subjective Health Complaints Inventory (SHC)</measure>
    <time_frame>Baseline, post intervention (at 8-14 weeks), 6, 12 and 36 months</time_frame>
    <safety_issue>No</safety_issue>
    <description>Assess level of subjective health complaints</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Nordic Musculoskeletal Screening Questionnaire</measure>
    <time_frame>Baseline, post intervention (at 8-14 weeks), 6, 12 and 36 months</time_frame>
    <safety_issue>No</safety_issue>
    <description>Assesses areas of bodily pain</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Stress subscale of the Depression, Anxiety and Stress scale (DASS 21)</measure>
    <time_frame>Baseline, post intervention (at 8-14 weeks), 6, 12 and 36 months</time_frame>
    <safety_issue>No</safety_issue>
    <description>Assesses patient's stress levels.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient Satisfaction Questionnaire</measure>
    <time_frame>At 8-14 weeks</time_frame>
    <safety_issue>No</safety_issue>
    <description>Assesses patient satisfaction</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Short-Form Orebro Musculoskeletal Screening Questionnaire (OMSQ)</measure>
    <time_frame>Measured at baseline</time_frame>
    <safety_issue>No</safety_issue>
    <description>Stratifies patients into low, medium or high risk of delayed pain recovery and chronicity.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Medication usage</measure>
    <time_frame>Baseline, post intervention (at 8-14 weeks), 6, 12 and 36 months</time_frame>
    <safety_issue>No</safety_issue>
    <description>To assess changes in levels of medication used.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Economic evaluation</measure>
    <time_frame>12 and 36 months</time_frame>
    <safety_issue>No</safety_issue>
    <description>Assesses direct and indirect costs of both treatment arms to see which is more cost-effective.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Level of co-interventions</measure>
    <time_frame>Baseline, post-intervention (at 8-14 weeks), 6, 12 and 36 months</time_frame>
    <safety_issue>No</safety_issue>
    <description>Assesses the number/type of healthcare services availed of throughout the intervention period.</description>
  </secondary_outcome>
  <number_of_arms>2</number_of_arms>
  <enrollment type="Anticipated">214</enrollment>
  <condition>Chronic Low Back Pain</condition>
  <arm_group>
    <arm_group_label>Individual Cognitive Functional Therapy</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>The intervention being tested has four main components: (1) a cognitive component, for each patient, their vicious cycle of pain will outlined in a diagram based on their findings from the examination and the Orebro Musculoskeletal Pain Screening Questionnaire; (2) specific movement exercises designed to normalize maladaptive movement behaviours; (3) targeted functional integration of activities in their daily life previously, reported to be avoided or provocative by the patient; and (4) a physical activity and lifestyle programme.</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Group Exercise Classes</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
    <description>6 classes will take place in total. The class has 3 components each week. First, a 30 minute talk and discussion on chronic pain, and some tips for participants. Second, a 40 minute exercise circuit, involving aerobic exercise, and gentle stretching and strengthening exercises. Finally, a 5 minute relaxation/mindfulness session will take place at the end. The total time involved is approximately 1 hour and 15 minutes.</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Individual Cognitive Functional Therapy</intervention_name>
    <description>Cognitive functional therapy (CFT) is a novel, patient centred behavioural intervention which addresses multiple dimensions in non-specific chronic low back pain (NSCLBP). It combines a functional behavioural approach of normalising provocative postures and movements while discouraging pain behaviours, with cognitive restructuring of the NSCLBP problem.</description>
    <arm_group_label>Individual Cognitive Functional Therapy</arm_group_label>
    <other_name>Classification-based cognitive functional therapy (CB-CFT)</other_name>
  </intervention>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Group Exercise Classes</intervention_name>
    <description>Each class involves a combination of education, exercise and relaxation/mindfulness. The education topics include pain and the nervous system, posture and ergonomics, exercise and relaxation and sleep. The exercise component includes 10 stations of a combination of aerobic, strength and flexibility exercises. These will be walking/jogging on the spot, mini-squats, sit to stands, wall push ups, bridging, step-ups and a combination of leg and low back stretches. The relaxation/mindfulness component will take place at the end of each class and will involve breathing and relaxation of the body.</description>
    <arm_group_label>Group Exercise Classes</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Aged between 18 and 75

          -  Chronic low back pain greater than 6 months duration

          -  Score greater than 14% for disability on Oswestry Disability Index (ODI)

          -  Independently mobile (with or without aids), to be capable of participating in a
             rehabilitation programme

        Exclusion Criteria:

          -  Primary pain area is not the lumbar spine (from T12-buttocks)

          -  Leg pain as the primary problem (nerve root compression or disc prolapse with true
             radicular pain/radiculopathy, lateral recess/central or spinal stenosis with primary
             leg pain)

          -  &lt;6 months post lumbar spine or lower limb or abdominal surgery

          -  Pain relieving procedures such as injection based therapy (e.g epidurals) and day
             case procedures (e.g rhizotomy) in the last 3 months

          -  Pregnancy

          -  Rheumatologic/inflammatory disease (e.g. rheumatoid arthritis (RA), ankylosing
             spondylitis (AS), psoriatic arthritis, lupus, scheuermann's disease)

          -  Progressive neurological disease (e.g. multiple sclerosis (MS), parkinson's disease
             (PD), motor neuron disease (MND)

          -  Unstable cardiac conditions

          -  Red flag disorders like malignancy/cancer, acute traumas like fracture (&lt;6 months
             ago) or infection, spinal cord compression/cauda equina
      </textblock>
    </criteria>
    <gender>Both</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>75 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Dr Kieran O' Sullivan, PhD</last_name>
    <role>Study Director</role>
    <affiliation>University of Limerick</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Mary O'Keeffe, BSc Physio</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Limerick</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Prof. Peter O'Sullivan, Professor</last_name>
    <role>Principal Investigator</role>
    <affiliation>Curtin University of Technology</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Dr Norelee Kennedy, PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>University of Limerick</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Prof. Wim Dankaerts, Professor</last_name>
    <role>Principal Investigator</role>
    <affiliation>Katholieke Universiteit Leuven</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Kieran O'Sullivan, PhD</last_name>
    <phone>061 234119</phone>
    <email>kieran.osullivan@ul.ie</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Mary O'Keeffe, BSc Physio</last_name>
    <phone>087 6726003</phone>
    <email>Mary.OKeeffe@ul.ie</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Mayo General Hospital</name>
      <address>
        <city>Mayo</city>
        <state>Connacht</state>
        <zip>0000</zip>
        <country>Ireland</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Lars Allworthy, BSc Physio</last_name>
      <phone>094 9021733</phone>
      <email>lars.allworthy@hse.ie</email>
    </contact>
    <investigator>
      <last_name>Lars Allworthy, BSc Physio</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Ballina Primary Care Centre</name>
      <address>
        <city>Mayo</city>
        <state>Connacht</state>
        <zip>0000</zip>
        <country>Ireland</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Aidan Tighe, BSc Physio</last_name>
      <phone>085 2405402</phone>
      <email>aidantighe@hotmail.com</email>
    </contact>
    <investigator>
      <last_name>Aidan Tighe, BSc Physio</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location>
    <facility>
      <name>Claremorris Primary Care Centre</name>
      <address>
        <city>Mayo</city>
        <state>Connacht</state>
        <zip>0000</zip>
        <country>Ireland</country>
      </address>
    </facility>
    <status>Not yet recruiting</status>
    <contact>
      <last_name>Louise Dolan, BSc Physio</last_name>
      <phone>094 9371739</phone>
      <email>louisedolan@yahoo.co.uk</email>
    </contact>
    <investigator>
      <last_name>Louise Dolan, BSc Physio</last_name>
      <role>Principal Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>Ireland</country>
  </location_countries>
  <reference>
    <citation>O'Sullivan P. It's time for change with the management of non-specific chronic low back pain. Br J Sports Med. 2012 Mar;46(4):224-7. doi: 10.1136/bjsm.2010.081638. Epub 2011 Aug 4. PubMed</citation>
    <PMID>21821612</PMID>
  </reference>
  <results_reference>
    <citation>Vibe Fersum K, O'Sullivan P, Skouen JS, Smith A, Kv√•le A. Efficacy of classification-based cognitive functional therapy in patients with non-specific chronic low back pain: A randomized controlled trial. Eur J Pain. 2013 Jul;17(6):916-28. doi: 10.1002/j.1532-2149.2012.00252.x. Epub 2012 Dec 4. PubMed PMID: 23208945.</citation>
    <PMID>23208945</PMID>
  </results_reference>
  <verification_date>May 2014</verification_date>
  <lastchanged_date>May 22, 2014</lastchanged_date>
  <firstreceived_date>April 30, 2014</firstreceived_date>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Non-specific chronic low back pain</keyword>
  <keyword>Cognitive functional therapy</keyword>
  <keyword>Exercise classes</keyword>
  <is_fda_regulated>No</is_fda_regulated>
  <has_expanded_access>No</has_expanded_access>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm  -->
    <mesh_term>Back Pain</mesh_term>
    <mesh_term>Low Back Pain</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                -->
</clinical_study>
